Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
10/15/18 8-K Current report filing
Documents
7
10/15/18 S-1 General form of registration statement for all companies including face-amount certificate companies
Documents
29
10/05/18 8-K Current report filing
Documents
64
09/19/18 8-K Current report filing
Documents
29
08/13/18 8-K Current report filing
Documents
12
08/10/18 10-Q Quarterly report pursuant to Section 13 or 15(d) 43
07/23/18 EFFECT Notice of Effectiveness 1
07/19/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 1
07/19/18 UPLOAD SEC-generated letter 1
07/13/18 CT ORDER Confidential treatment order 1
RSS